Coronary Polyarteritis Nodosa: Clinical Dilemmas in Diagnosis and Management

Batool Jamal AbuHalimeh1, Stefan Sanger1, Laszlo Gobolos1

  • 1Heart, Vascular and Thoracic Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE.

JACC. Case Reports
|July 11, 2025
PubMed

Insights

Polyarteritis nodosa (PAN) involving the coronary arteries requires aggressive immunotherapy and cardiovascular risk management. A multidisciplinary approach is crucial for optimizing patient outcomes in this rare condition.

Area of Science:

  • Cardiovascular Medicine
  • Rheumatology
  • Immunology

Background:

  • Polyarteritis nodosa (PAN) is a systemic vasculitis that can affect the coronary arteries, leading to severe cardiovascular complications.
  • Coronary involvement in PAN is rare but carries a high risk of morbidity and mortality.

Observation:

  • A 43-year-old woman presented with complex coronary artery abnormalities, including irregularities, triple-vessel stenosis, aneurysmal dilatation, and collateral formation.
  • The patient was diagnosed with polyarteritis nodosa (PAN) with significant coronary artery involvement.

Findings:

  • Treatment involved aggressive immunotherapy with high-dose corticosteroids, mycophenolate, and rituximab to control systemic inflammation.
  • Antithrombotic therapy, statins, ACE inhibitors, and smoking cessation were initiated for cardiovascular risk management.
  • Despite triple-vessel disease, surgical intervention was deferred due to patient stability, with medical management leading to symptomatic improvement.

Implications:

  • Coronary PAN necessitates a comprehensive, multidisciplinary approach for accurate diagnosis and effective management.
  • Medical therapy, including immunotherapy and cardiovascular risk reduction, is the cornerstone of treatment, with surgical options reserved for select cases.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
37
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
40
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
26
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
33
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
17
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
40